AstraZeneca Announces The Opening Of Its Newest Global Strategic Research And Development Center, In Kendall Square, Cambridge, Massachusetts; Co. invests $1B To Grow Massachusetts Workforce By Over 50%

AstraZeneca has opened a new global strategic research and development center in Kendall Square, Cambridge, Massachusetts, as part of a $1 billion investment. This initiative aims to increase the company's workforce in Massachusetts by over 50% and enhance the development of next-generation medicines. The facility strengthens AstraZeneca's presence in a key life sciences hub.